Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Pre-Market, Observational, Prospective, Blinded, Controlled, Single-Center Study to Assess the Safety and Performance of Kenko Breast AI+ Medical Device as an Aid to Breast Cancer Diagnosis in Adult Women

NCT07580105 is registered in ClinicalTrials.gov with Kenko Imalytics S.L. as lead sponsor.

NCT NCT07580105
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07580105 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Pre-Market, Observational, Prospective, Blinded, Controlled, Single-Center Study to Assess the Safety and Performance of Kenko Breast AI+ Medical Device as an Aid to Breast Cancer Diagnosis in Adult Women
Lead sponsor
Kenko Imalytics S.L.
Phase
Observational
Overall status
Recruiting
Start date
July 22, 2026
Completion date
May 31, 2027
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer